Hims & Hers Health, Inc. (HIMS) stock
HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30171% above fair value
$17.05−0.50 (-2.85%)
Close on Nov 18, 2026Market cap $3.98BP/E –Yield –
Hims & Hers Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Hims & Hers Health's revenue for the twelve months ending Jun 30, 2026 was $2.58B, up 28.0% year over year. For fiscal 2025 it was $2.35B, up 59.0% from the year before. The highest annual figure on record is $2.35B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.35B | +59.0% |
| FY2024 | Dec 31, 2024 | $1.48B | +69.3% |
| FY2023 | Dec 31, 2023 | $872.00M | +65.5% |
| FY2022 | Dec 31, 2022 | $526.92M | +93.8% |
| FY2021 | Dec 31, 2021 | $271.88M | +82.8% |
| FY2020 | Dec 31, 2020 | $148.76M | +80.2% |
| FY2019 | Dec 31, 2019 | $82.56M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $753.21M | +38.2% |
| Q1 FY2026 | Mar 31, 2026 | $608.10M | +3.8% |
| Q4 FY2025 | Dec 31, 2025 | $617.82M | +28.4% |
| Q3 FY2025 | Sep 30, 2025 | $598.98M | +49.2% |
| Q2 FY2025 | Jun 30, 2025 | $544.83M | +72.6% |
| Q1 FY2025 | Mar 31, 2025 | $586.01M | +110.7% |
| Q4 FY2024 | Dec 31, 2024 | $481.14M | +95.1% |
| Q3 FY2024 | Sep 30, 2024 | $401.56M | +77.1% |
| Q2 FY2024 | Jun 30, 2024 | $315.65M | +51.8% |
| Q1 FY2024 | Mar 31, 2024 | $278.17M | +45.8% |
| Q4 FY2023 | Dec 31, 2023 | $246.62M | +47.5% |
| Q3 FY2023 | Sep 30, 2023 | $226.70M | +56.5% |
| Q2 FY2023 | Jun 30, 2023 | $207.91M | +83.1% |
| Q1 FY2023 | Mar 31, 2023 | $190.77M | +88.3% |
| Q4 FY2022 | Dec 31, 2022 | $167.20M | +97.4% |
| Q3 FY2022 | Sep 30, 2022 | $144.84M | +95.3% |
| Q2 FY2022 | Jun 30, 2022 | $113.56M | +87.1% |
| Q1 FY2022 | Mar 31, 2022 | $101.31M | +93.7% |
| Q4 FY2021 | Dec 31, 2021 | $84.70M | +104.3% |
| Q3 FY2021 | Sep 30, 2021 | $74.17M | +79.5% |
| Q2 FY2021 | Jun 30, 2021 | $60.69M | +69.0% |
| Q1 FY2021 | Mar 31, 2021 | $52.31M | +74.0% |
| Q4 FY2020 | Dec 31, 2020 | $41.47M | – |
| Q3 FY2020 | Sep 30, 2020 | $41.32M | – |
| Q2 FY2020 | Jun 30, 2020 | $35.90M | – |
| Q1 FY2020 | Mar 31, 2020 | $30.06M | – |
See a number that looks wrong?